Optimmune is an ophthalmic ointment with ciclosporin as the active ingredient for the treatment of pannus and chronic idiopathic keratoconjunctivitis sicca in dogs. It is a veterinary product produced by Intervet, which is part of Merck. Optimmune was invented by Dr. Renee Kaswan, a DVM and professor at The University of Georgia. Dr. Kaswan is also the inventor of Restasis, the pharmaceutical that is the human version of Optimmune.
Optimmune is one of a very few drugs developed for animals and then modified for use in human medicine.
White petrolatum-based ointment for ophthalmic use, containing 0.2% w/w ciclosporin Ph Eur.
Ciclosporin is an immunosuppressant with lacrimomimetic and anti-inflammatory properties.
Mild irritation in first few days of treatment. Treatment should be discontinued and professional advice sought. Do not use if fungal infection of the eye is suspected.
- 3.5-Gram tubes
In Canada, available only from veterinary with prescription. As of October 2011, a tube cost $72.
This article does not cite any sources. (March 2014) (Learn how and when to remove this template message)
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|
|This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it.|